As per MRFR analysis, the US Fertility Testing Market Size was estimated at 123.9 (USD Million) in 2023. The US Fertility Testing Market Industry is expected to grow from 136.5(USD Million) in 2024 to 400 (USD Million) by 2035. The US Fertility Testing Market CAGR (growth rate) is expected to be around 10.268% during the forecast period (2025 - 2035).
The US Fertility Testing Market is currently seeing several significant trends shaped by societal, technological, and healthcare movements. A notable trend is the increasing awareness and demand for fertility testing among couples looking to conceive. This rise is partly influenced by the growing focus on reproductive health, especially among millennials and Generation Z. Additionally, there is a heightened acceptance of fertility issues, leading to more couples seeking proactive testing options.
Key market drivers include advancements in technology, which have made home testing kits more accessible and user-friendly. These innovations enable individuals to carry out tests in the comfort of their own homes, thus removing some of the stigma associated with seeking help for fertility problems. Opportunities to be explored in this market include the development of more comprehensive testing kits that can address a broader range of fertility issues.
These could incorporate biomarkers that provide insights into ovulation, sperm health, and overall reproductive health. Furthermore, there is potential for collaboration between fertility testing companies and healthcare providers to create integrated solutions that combine testing with personalized treatment advice. Recent trends also spotlight a shift towards personalized healthcare, where consumers are looking for tailored solutions based on their unique medical backgrounds.
As telehealth services expand, many users are likely to seek online consultations coupled with at-home testing, thus transforming how fertility issues are addressed. Overall, these trends signify a changing landscape in the US Fertility Testing Market, with a focus on accessibility, personalization, and the integration of technology to support reproductive health.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
In the United States, there has been a significant rise in awareness about infertility issues among the population. According to the Centers for Disease Control and Prevention (CDC), approximately 12% of women in the U.S., or about 7.3 million, have faced difficulty in getting pregnant or carrying a pregnancy to term. This growing awareness leads to increased demand for fertility testing solutions, aligning with the trends in the US Fertility Testing Market Industry.
Additionally, various public health campaigns and educational resources aimed at increasing awareness are being supported by organizations such as the American Society for Reproductive Medicine (ASRM), which has been crucial in disseminating information about fertility health and the importance of early testing. The result is an upward trajectory in the US Fertility Testing Market as more individuals seek testing upon learning about their fertility health options, thereby contributing to market growth and a greater understanding of reproductive health overall.
The US Fertility Testing Market Industry is experiencing substantial growth due to continuous technological advancements. Innovations in home testing kits, which allow individuals to test their fertility at home conveniently, are gaining popularity. Market leaders like Proov and Ava have developed sophisticated ovulation detection technologies that utilize hormone monitoring to facilitate fertility awareness. A report by the U.S. Food and Drug Administration (FDA) indicates that home fertility tests have seen a double-digit growth rate in the last five years, primarily due to improvements in the accuracy and ease of use of these devices.
These advancements cater to the increasing demand for accessible fertility testing solutions, thereby enhancing the market landscape significantly.
In the United States, there is a noticeable trend towards delayed parenthood, primarily influenced by evolving societal norms and career-focused lifestyles. According to the National Center for Health Statistics, the average age of first-time mothers has increased to 27 years as of 2018, up from 24.9 years in the early 2000s. With increasing age, fertility naturally declines, leading to a growing need for fertility testing to address potential issues.
The US Fertility Testing Market Industry is expected to benefit from this shift as individuals who delay pregnancy are more likely to seek fertility testing solutions when they do decide to start a family. This change in parenthood timing is supported by various organizations that advocate for family planning and reproductive health, further enhancing the market's potential.
The US Fertility Testing Market for the Product segment is rapidly evolving, driven by advancements in technology and increasing awareness regarding reproductive health. Ovulation Predictor Kits are gaining popularity as they offer women precise tools to track their ovulation cycles, leading to improved chances of conception. These kits play a crucial role for couples trying to conceive, as they provide real-time data on fertility windows, facilitating better planning and timing.
Another essential product in the market is Fertility Monitors, which cater to a growing consumer base seeking more comprehensive monitoring solutions. These monitors not only track ovulation but also provide insights into hormone levels and fertility trends, making them an attractive option for users looking for a thorough understanding of their reproductive health. Male Fertility Testing Products are also seeing significant traction, reflecting a growing awareness about male factors in infertility.
As societal norms evolve, men are becoming more proactive in assessing their reproductive health, thus driving the demand for at-home testing options that allow them to monitor their sperm health without the stigma associated with clinical testing. Overall, these products represent a significant aspect of the US Fertility Testing Market and cater to a demographic that places high importance on reproductive planning and health monitoring.
The growing trends in health consciousness and increased accessibility to these products are contributing to their acceptance and urging the industry toward further innovation. The concerted efforts by manufacturers to enhance product reliability and ease of use are anticipated to bolster market penetration. Additionally, government initiatives aimed at improving healthcare access and education on fertility health further support the potential growth of these product categories in the market landscape. As awareness around reproductive health challenges continues to grow, it creates a substantial opportunity for various products in the US Fertility Testing Market to expand their reach and impact among consumers.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Fertility Testing Market encompasses various sample types, including saliva, urine, blood, and others, each playing a pivotal role in understanding reproductive health. Saliva-based tests are gaining traction due to their ease of use and non-invasive nature, which appeal to consumers seeking convenient home-testing options. Urine tests are widely recognized for their reliability in detecting ovulation, contributing significantly to the market as they facilitate family planning.
Blood tests, although more invasive, provide critical hormone level assessments that are essential for comprehensive fertility evaluations, making them indispensable in clinical settings. The ongoing growth in the US Fertility Testing Market reflects increasing public awareness of fertility issues and a rising prevalence of conditions affecting reproductive health. This uptick is supported by broader societal shifts towards proactive health monitoring and self-care, with individuals empowered to take charge of their fertility journey.
Despite challenges such as high costs and regulatory hurdles, the market is poised for considerable expansion, driven by continuous innovation in testing technologies and a surge in demand for at-home fertility solutions.
The US Fertility Testing Market exhibits a diverse Mode of Purchase that caters to varying consumer preferences and needs. The market is primarily split into Prescription-Based and Over-The-Counter (OTC)-Based purchases, which are pivotal for customer accessibility. Prescription-Based options are often recommended by healthcare professionals and provide a sense of reassurance and clinical oversight, ensuring that users receive products tailored to their specific needs.
Meanwhile, OTC-Based options are increasingly popular due to their ease of access and convenience, allowing consumers to initiate testing without medical appointments, which appeals to the growing number of individuals seeking to monitor their fertility at home. This shift towards OTC products is also supported by advancements in technology and increasing awareness surrounding fertility issues among the general public, leading to market growth.
As more individuals in the US explore their fertility options, these channels become essential in facilitating timely access to testing solutions, ultimately reflecting the dynamics of the US Fertility Testing Market. With a rising emphasis on reproductive health in the US, both Prescription-Based and OTC-Based modalities serve critical functions in ensuring consumers have choices that best meet their lifestyle and personal healthcare needs.
The End-User segment of the US Fertility Testing Market plays a crucial role in shaping the landscape of fertility services. This segment encompasses various environments, including Home Care Settings, Hospitals, Fertility Clinics, and others, each contributing unique dynamics to the overall market. Home Care Settings have gained traction, driven by a growing preference for privacy and convenience among individuals seeking fertility solutions, allowing users to conduct tests discreetly.
Hospitals continue to offer comprehensive care, providing advanced diagnostic tools and treatments, often playing a central role in managing complex fertility cases. Fertility Clinics are significant players that offer specialized services and personalized care tailored to individual patient needs, with many clients seeking expert assistance in achieving their reproductive goals. Meanwhile, other environments also contribute, serving diverse needs within the overall fertility landscape.
As the US faces challenges such as a rising average maternal age and increased awareness of infertility, these settings are positioned to meet the escalating demand for effective fertility solutions. The integration of technology, such as telehealth and at-home testing kits, enhances access and convenience, further driving market growth. These trends indicate the evolving nature of the US Fertility Testing Market and underscore the importance of understanding the varying demands across different End-User categories.
The US Fertility Testing Market has seen significant growth and diversification over recent years, driven by rising awareness of fertility issues and advancements in testing technologies. This market is characterized by various players offering an array of products, ranging from at-home testing kits to professional laboratory services. Companies in this sector have developed innovative solutions to cater to a diverse clientele, which includes individuals planning families and those coping with infertility challenges.
The competitive landscape is influenced by factors such as regulatory approvals, product effectiveness, branding strategies, and partnerships that enhance distribution capabilities. Companies are also increasingly focusing on digital transformation to provide comprehensive online support and education, thereby improving customer engagement and satisfaction. Progenity has established a strong foothold in the US Fertility Testing Market, leveraging its position through innovative testing solutions and a robust product portfolio.
The company specializes in providing advanced genetic testing that enables healthcare providers to deliver personalized care to their patients. Progenity’s strengths lie in its commitment to research and development, which has led to the creation of highly accurate and reliable testing products. Their strong collaborations with healthcare professionals and institutions enhance their market presence, ensuring that they remain at the forefront of fertility diagnostics. With a focus on quality and advanced technology, Progenity is well-positioned to address growing consumer needs in the fertility testing arena, solidifying its reputation as a trusted name in the industry.
Zywave has also carved out an influential role in the US Fertility Testing Market, known for its emphasis on providing comprehensive fertility solutions. The company offers a range of key products and services, including online resources that facilitate better understanding and management of fertility issues. Zywave’s strengths are highlighted by its dedication to customer education and support, which fosters a loyal customer base.
Recent mergers and acquisitions have enabled Zywave to enhance its service offerings and expand its market share, allowing it to provide a more extensive suite of fertility testing options to consumers. The company’s strategic initiatives focus on leveraging partnerships to enhance product distribution and clinical support, further solidifying its competitive edge in this rapidly evolving market.
The US Fertility Testing Market has been experiencing notable developments recently, particularly in the area of innovation and partnerships. Progenity continues to expand its portfolio, focusing on non-invasive genetic testing solutions aimed at improving fertility outcomes. Zywave has been enhancing its digital platforms to support fertility tracking and monitoring. Cypress Diagnostics introduced new diagnostic tests that have gained traction among fertility clinics.
In terms of market dynamics, CooperSurgical and LabCorp are exploring collaborative efforts to streamline testing processes, which is expected to enhance patient access to fertility solutions. Thermo Fisher Scientific and SomaLogic are investing in advanced technologies to develop precision fertility testing products. Additionally, Abbott Laboratories and Quest Diagnostics have reported significant growth in their fertility testing services, reflecting an increased demand driven by the rising awareness regarding reproductive health.
In a recent merger, Ferring Pharmaceuticals announced its acquisition of a niche fertility testing firm in May 2023, positioning itself to broaden its offerings in the fertility sector. The overall market is witnessing a growth trend, influenced by technological advancements and increased public interest, particularly among younger demographics concerned with fertility health.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 123.9(USD Million) |
| MARKET SIZE 2024 | 136.5(USD Million) |
| MARKET SIZE 2035 | 400.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.268% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Progenity, Zywave, Cypress Diagnostics, CooperSurgical, LabCorp, Thermo Fisher Scientific, SomaLogic, Abbott Laboratories, Quest Diagnostics, Invitae, Ferring Pharmaceuticals, Merck KGaA, Everlywell, Natera, Bayer AG |
| SEGMENTS COVERED | Product, Sample, Mode of Purchase, End-User |
| KEY MARKET OPPORTUNITIES | Telehealth integration for consultations, Home testing kit innovation, Personalized fertility solutions, Affordable screening services, Increased awareness and education programs |
| KEY MARKET DYNAMICS | rising infertility rates, increased awareness of fertility, advancements in testing technology, growing acceptance of home testing, expanding fertility health insurance coverage |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Fertility Testing Market is expected to be valued at 136.5 million USD in 2024.
By 2035, the market is projected to reach a valuation of 400.0 million USD.
The expected CAGR for the US Fertility Testing Market from 2025 to 2035 is 10.268 percent.
The Ovulation Predictor Kits segment is anticipated to dominate the market with a value of 45.0 million USD in 2024.
The Male Fertility Testing Products segment is projected to reach 80.0 million USD by 2035.
Major players include Progenity, Zywave, CooperSurgical, and LabCorp among others.
Rising infertility rates and increasing awareness about fertility testing are key growth drivers.
Fertility Monitors are expected to reach a market size of 100.0 million USD by 2035.
Current market trends show a growing demand for home-based fertility testing solutions.
Challenges include regulatory hurdles and competition from alternative reproductive technologies.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
